Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524064 · ClinicalTrials.gov registry record · NA
FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax
A NA study of Bone Metastases in the Thorax, sponsored by Varian, a Siemens Healthineers Company.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT05524064: Active NA study of Bone Metastases in the Thorax, sponsored by Varian, a Siemens Healthineers Company.
NCT05524064 is a NA study of Bone Metastases in the Thorax that is active but no longer recruiting, run by Varian, a Siemens Healthineers Company. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05524064, a NA study of Bone Metastases in the Thorax, is active but no longer recruiting, sponsored by Varian, a Siemens Healthineers Company.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess toxicities of FLASH radiotherapy treatment and pain relief in subjects with painful thoracic bone metastases. FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.
Primary Outcome
Toxicities that are possibly, probably, or definitely related to FLASH radiotherapy. Toxicities will be classified per CTCAE version 5.0.
Conditions Studied
Interventions
- RADIATION FLASH Radiotherapy
Study Locations (2)
Illinois
- OSF Healthcare Saint Francis Medical Center - Peoria
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-03-08 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What the registry record for NCT05524064 still lists
NCT05524064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Bone Metastases in the Thorax appearing as the primary indexed condition, and to 1 intervention - of which FLASH Radiotherapy is the first listed.
NCT05524064 reports a single indexed study location in Illinois, Ohio.
Frequently Asked Questions
What is clinical trial NCT05524064 about?
NCT05524064 is a clinical study titled "FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax". The purpose of this study is to assess toxicities of FLASH radiotherapy treatment and pain relief in subjects with painful thoracic bone metastases. FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.
What is the current status of trial NCT05524064?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-03-08. Estimated completion is 2027-05-01.
What conditions does trial NCT05524064 study?
This clinical trial studies the following conditions: Bone Metastases in the Thorax.
What interventions are being tested in trial NCT05524064?
The interventions under investigation include: FLASH Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT05524064?
This trial is sponsored by Varian, a Siemens Healthineers Company, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05524064 being conducted?
This trial has 2 study locations across Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05524064's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI